Abstract
As physicians who treat pain, we know firsthand the battles our patients face in gaining access to appropriate treatment, which, when other less aggressive options will not suffice, includes opioids. The ongoing battle gained a new front recently when Walgreens pharmacy chain changed its procedures regarding the processing of prescriptions for controlled substances [1]. The new policy directs its pharmacists, at the point of dispensing, to contact prescribers for such detailed medical information as diagnoses, International Classification of Diseases Ninth Revision codes, patient treatment plans, expected length of therapy, and previously tried medications. This policy has raised concerns for prescribers of pain medications that such demands [2,3]: The leaders of the American Academy of Pain Medicine share these concerns. The pharmacist does not have access to the medical record and may not possess specific knowledge about the practice of pain medicine. It is not within …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
